Fatty liver ‘independently increases Type 2 diabetes risk’ In a new study, scientists have found that individuals with fatty liver were five times more likely to develop Type 2 diabetes than t h o s e without fatty liver. This higher risk seemed to occur regardless of the patient’’s fasting insulin levels, which were used as a marker of insulin resistance.
ww
1st
om .c
NEWS UPDATE
dgatetod ay me w.
Anniversary
Soon, nasal spray vaccine to fight Alzheimer’’s, stroke Tel Aviv University researchers are working on a nasally delivered vaccine that promises to protect against Alzheimer’s as well as stroke. The new vaccine repairs vascular damage in the brain by using the body’’s own immune system and, in addition to its prophylactic effect, it can work even when Alzheimer’’s symptoms are already present.
“Using part of a drug that was previously tested as an influenza drug, we’’ve managed to successfully induce an immune response against amyloid proteins in the blood vessels,” said Dan Frenkel, who collaborated on this project with Prof. Howard L. Weiner of Brigham and Women’’s Hospital, Harvard Medical School.
Scalp cooling cap may help patients undergoing chemotherapy keep hair Wake Forest University Baptist Medical Center will conduct a feasibility study to test the use of a scalp cooling device that breast cancer patients will wear while undergoing chemotherapy treatment. This will be part of the first significant study of the medical device in the United States. The FDA has given approval for an investigational device exemption (IDE) feasibility study to be conducted at both Wake Forest Baptist and University of California, San Francisco (UCSF). A total of 20 patients with stage one breast cancer will be involved - 10 at Wake Forest Baptist and 10 at UCSF. The study will test the safety and tolerability of the patented DigniCap scalp cooling system, which is worn by patients during chemotherapy treatment to prevent hair loss.
18
Mar - Apr 2011